Patents by Inventor Ting Xu

Ting Xu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210144028
    Abstract: In a virtual extensible local area network (VXLAN) packet encapsulation and policy execution method, a communications device determines an application identifier for identifying an application type of an Ethernet frame, and places the application identifier in a VXLAN header. Another device may directly execute a corresponding policy based on the application identifier in the VXLAN header and without analyzing a packet.
    Type: Application
    Filed: January 25, 2021
    Publication date: May 13, 2021
    Inventors: Bin Yu, Ting Xu
  • Publication number: 20210115143
    Abstract: Fully human anti-PD-L1 antibodies and their corresponding applications. Fully human antibodies capable of specifically binding to human PD-L1 were obtained by employing a yeast display library-based screening technique and also by affinity maturation to further improve their affinity for PD-L1. The fully human anti-PD-L1 antibodies show good specificity, affinity and stability. They are capable of enhancing T cell activity by binding to activated T cells, while significantly inhibiting tumor growth, and can be used in the diagnosis and treatment of PD-L1-related cancers and other associated diseases.
    Type: Application
    Filed: April 18, 2018
    Publication date: April 22, 2021
    Applicant: R-PHARM OVERSEAS, INC.
    Inventors: Yan LAVROVSKY, Ting XU, Sergei BARBASHOV, Alexey REPIK, Mikhail SAMSONOV, Vasily IGNATIEV, Shorena ARCHUADZE
  • Publication number: 20210095031
    Abstract: The present disclosure provides a dimer formed by two polypeptide chains, with each of the two polypeptide chains comprising an antibody Fc subunit, wherein the dimer comprises two or more immunoglobulin single variable domains (ISVDs), at least one of the ISVDs is specific for PD-L1, and at least one of the ISVDs is specific for CTLA4.
    Type: Application
    Filed: September 30, 2020
    Publication date: April 1, 2021
    Applicant: JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD.
    Inventors: Ting Xu, Kangping Guo, Dong Yang, Pilin Wang, Yuhao Jin, Xiaoxiao Wang
  • Publication number: 20210070885
    Abstract: The present application provides a bispecific antibody or an antibody mixture with common light chains and a preparation method therefor. the present application also provides a nucleic acid molecule encoding the antibody or the mixture, a recombinant vector and a recombinant cell comprising the nucleic acid molecule, as well as a detection and quantitation method for the antibody or the mixture.
    Type: Application
    Filed: September 16, 2020
    Publication date: March 11, 2021
    Inventors: Ting XU, Tao XU, Xiaoxiao WANG, Qian LI, Minjie PANG, Huimin ZHANG, Li HAN, Qingqing ZHANG
  • Publication number: 20210000082
    Abstract: Aspects of the present disclosure relate to a bird bath. In one configuration, a frame as a plurality lighting elements therein. A stand is provided for supporting the frame. The bath may include a control component for controlling the lighting elements and a photovoltaic cell for providing power to the lighting elements. In another aspect, the frame may include a plurality of spiral frame members. In yet another aspect, the spiral members have a channel pathway and the lighting elements are disposed in the channel pathway. In yet another aspect, the frame may includes a plurality of radial members. In yet another aspect, the radial members have a channel pathway and the lighting elements are disposed in the channel pathway.
    Type: Application
    Filed: July 2, 2019
    Publication date: January 7, 2021
    Inventors: Ting Xu, Kristina Sarullo, Jordan Cai
  • Patent number: 10875926
    Abstract: Disclosed are a fully human monoclonal antibody specifically binding to a CD137 or an antigen binding portion thereof. On one hand, provided are a CDR/variable region sequence of the antibody and an encoding nucleic acid sequence thereof; on the other hand, provided is a method for treating diseases using the antibody or the antigen binding portion thereof. a fully human monoclonal antibody specifically binding to a CD137 or an antigen binding portion thereof. On one hand, provided are a CDR/variable region sequence of the antibody and an encoding nucleic acid sequence thereof; on the other hand, provided is a method for treating diseases using the antibody or the antigen binding portion thereof.
    Type: Grant
    Filed: September 22, 2015
    Date of Patent: December 29, 2020
    Assignee: Dingfu Biotarget Co., Ltd.
    Inventors: Ting Xu, Yan Luan, Xiaoxiao Wang, Jianjian Peng, Shuli Ma, Hui Ma, Xiaolong Pan, Shilong Fu, Shanshan Ning, Yeqiong Fei, Meng Zhao
  • Patent number: 10850209
    Abstract: The present invention discloses a foldable pinwheel, which comprises a central pole (1); and a blade assembly rotatably disposed on the central pole (1); the blade assembly comprises a plurality of rotary blades (2) and at least one locking mechanism (4), which is rotatably disposed on the central pole (1); the plurality of rotary blades (2) can be stacked up together when the locking mechanism (4) is in an unlocked state, and the locking mechanism (4) can secure the plurality of rotary blades (2) in a stacked up position. The folding and unfolding of rotary blades are realized by a locking mechanism. The overall volume can be effectively reduced during transportation or storage. When in use, the pinwheel can be mounted quickly. It is convenient and fast.
    Type: Grant
    Filed: February 15, 2019
    Date of Patent: December 1, 2020
    Assignee: Ningbo Shuosi Trading Co., Ltd.
    Inventor: Ting Xu
  • Publication number: 20200354478
    Abstract: Provided are proteinaceous heterodimers, pharmaceutical compositions, medicaments and/or kits comprising the proteinaceous heterodimers, methods for producing the proteinaceous heterodimers, and uses thereof.
    Type: Application
    Filed: June 13, 2018
    Publication date: November 12, 2020
    Applicant: DINGFU BIOTARGET CO., LTD.
    Inventors: Ting XU, Yan LUAN, Jianjian PENG, Kai FU, Meng ZHAO, Xiaoxiao WANG
  • Patent number: 10806702
    Abstract: The present invention provides bis-polymer lipid-peptide conjugates containing a hydrophobic block and headgroup containing a helical peptide and two polymer blocks. The conjugates can self-assemble to form helix bundle subunits, which in turn assemble to provide micellar nanocarriers for drug cargos and other agents. Particles containing the conjugates and methods for forming the particles are also disclosed.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: October 20, 2020
    Assignee: The Regents of the University of California
    Inventors: Ting Xu, He Dong, Jessica Shu, Nikhil Dube
  • Patent number: 10808043
    Abstract: The present application provides a bispecific antibody or an antibody mixture with common light chains and a preparation method therefor. the present application also provides a nucleic acid molecule encoding the antibody or the mixture, a recombinant vector and a recombinant cell comprising the nucleic acid molecule, as well as a detection and quantitation method for the antibody or the mixture.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: October 20, 2020
    Assignee: Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
    Inventors: Ting Xu, Tao Xu, Xiaoxiao Wang, Qian Li, Minjie Pang, Huimin Zhang, Li Han, Qingqing Zhang
  • Publication number: 20200318154
    Abstract: Compositions comprise statistically random heteropolymers complexed with active proteins, and are formulated and used in stimuli-responsive materials and nanoreactors composed of proteins and synthetic materials.
    Type: Application
    Filed: June 21, 2020
    Publication date: October 8, 2020
    Applicant: The Regents of the University of California
    Inventors: Ting Xu, Brian Panganiban, Tao Jiang
  • Publication number: 20200277350
    Abstract: Provided are proteinaceous heterodimers, pharmaceutical compositions, medicaments and/or kits comprising the proteinaceous heterodimers, methods for producing the proteinaceous heterodimers, and uses thereof.
    Type: Application
    Filed: September 21, 2018
    Publication date: September 3, 2020
    Inventors: Ting XU, Yan LUAN, Jianjian PENG, Shilong FU
  • Patent number: D895295
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: September 8, 2020
    Assignee: SHENZHEN LIBAI TECHNOLOGY CO., LTD.
    Inventor: Ting Xu
  • Patent number: D899410
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: October 20, 2020
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Ting Xu, Liang Chang, Yang Wan, Haibo Luo
  • Patent number: D899888
    Type: Grant
    Filed: May 25, 2020
    Date of Patent: October 27, 2020
    Inventor: Ting Xu
  • Patent number: D904601
    Type: Grant
    Filed: August 29, 2019
    Date of Patent: December 8, 2020
    Inventor: Ting Xu
  • Patent number: D912169
    Type: Grant
    Filed: July 23, 2020
    Date of Patent: March 2, 2021
    Inventor: Ting Xu
  • Patent number: D914024
    Type: Grant
    Filed: September 21, 2018
    Date of Patent: March 23, 2021
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Joon Suh Kim, Ting Xu, Zhenqi Tang, Haibo Luo, Ying Zhao, Haiyan Hu, Meng Li, Ze Yuan
  • Patent number: D914632
    Type: Grant
    Filed: February 24, 2019
    Date of Patent: March 30, 2021
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Joon Suh Kim, Ting Xu, Guoping Wu, Jiaxi Wang, Jue Yuan
  • Patent number: D918319
    Type: Grant
    Filed: July 24, 2020
    Date of Patent: May 4, 2021
    Inventor: Ting Xu